Mrv0541 02231218002D 18 19 0 0 0 0 999 V2000 3.7935 0.9644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.2617 -0.5750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.0241 -1.2896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.7176 0.8033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.7176 -0.5245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.0241 0.1394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 0.5519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 -0.2731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 0.5519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 0.9644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 -0.6856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1991 0.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.5519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 -0.2731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 0.9644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 0.5519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4366 -0.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.6742 -1.2896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 9 1 0 0 0 0 1 13 1 0 0 0 0 2 17 1 0 0 0 0 2 18 1 0 0 0 0 3 17 2 0 0 0 0 4 7 1 0 0 0 0 4 12 1 0 0 0 0 5 8 1 0 0 0 0 5 12 2 0 0 0 0 6 12 1 0 0 0 0 6 17 1 0 0 0 0 7 8 2 0 0 0 0 7 10 1 0 0 0 0 8 11 1 0 0 0 0 9 10 2 0 0 0 0 9 14 1 0 0 0 0 11 14 2 0 0 0 0 13 15 1 0 0 0 0 15 16 1 0 0 0 0 M END > DB04910 > drugbank > CCCOC1=CC2=C(C=C1)N=C(NC(=O)OC)N2 > InChI=1S/C12H15N3O3/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16) > RAOCRURYZCVHMG-UHFFFAOYSA-N > C12H15N3O3 > 249.2658 > 249.111341361 > 4 > 33 > 0.0013365325859504757 > 26.976159801145588 > 1 > 2 > 0 > 1 > methyl N-(6-propoxy-1H-1,3-benzodiazol-2-yl)carbamate > 2.07 > 2.522414591333333 > -2.86 > 0 > 0 > 2 > 0 > 13.946391006014558 > 9.644972089169237 > 4.5574244372555786 > 76.24000000000001 > 66.6642 > 5 > 1 > 3.47e-01 g/l > tetrahydrofolic acid > 0 > DB04910 > investigational; vet_approved > Oxibendazole > 5-Propoxy-2-benzimidazolecarbamic acid methyl ester; Methyl 5-n-propoxy-2-benzimidazole carbamate; Methyl 5-propoxy-2-benzimidazolecarbamate; Oxibendazole; Oxibendazolo; Oxibendazolum $$$$